The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

被引:182
作者
Gisslen, Magnus [1 ]
Price, Richard W. [2 ]
Nilsson, Staffan [3 ]
机构
[1] Univ Gothenburg, Dept Infect Dis, Sahlgrenska Univ Hosp, Gothenburg, Sweden
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[3] Chalmers Univ Technol, Dept Math Stat, S-41296 Gothenburg, Sweden
关键词
IMPAIRMENT; DISEASE; DEMENTIA; FLUID; ERA;
D O I
10.1186/1471-2334-11-356
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: A substantial prevalence of mild neurocognitive disorders has been reported in HIV, also in patients treated with combination antiretroviral therapy (cART). This includes a new disorder that has been termed asymptomatic neurocognitive impairment (ANI). Discussion: ANI is identified by performance on formal neuropsychological testing that is at least 1 SD below the mean of normative scores in at least two cognitive domains out of at least five examined in patients without associated symptoms or evident functional impairment in daily living. While two tests are recommended to assess each domain, only one is required to fulfill this diagnostic criterion. Unfortunately, this definition necessitates that about 20% of the cognitively normal HIV-infected population is classified as suffering ANI. This liberal definition raises important ethical concerns and has as well diagnostic and therapeutic implications. Since neither its biological substrate, prognostic significance nor therapeutic implications are clearly established, we recommend that this diagnosis be modified or applied cautiously. Summary: The diagnoses of less severe forms of neurocognitive disorders in HIV relies on the outcomes of neuropsychological testing, and a high proportion of HIV-infected patients with effective cART may be classified as neurocognitively abnormal using the current criteria. The definition of ANI is not stringent, and results in approximately 20% of the population being classified as abnormal. To us this seems an unacceptable false-positive rate.
引用
收藏
页数:4
相关论文
共 15 条
[1]   Updated research nosology for HIV-associated neurocognitive disorders [J].
Antinori, A. ;
Arendt, G. ;
Becker, J. T. ;
Brew, B. J. ;
Byrd, D. A. ;
Cherner, M. ;
Clifford, D. B. ;
Cinque, P. ;
Epstein, L. G. ;
Goodkin, K. ;
Gisslen, M. ;
Grant, I. ;
Heaton, R. K. ;
Joseph, J. ;
Marder, K. ;
Marra, C. M. ;
McArthur, J. C. ;
Nunn, M. ;
Price, R. W. ;
Pulliam, L. ;
Robertson, K. R. ;
Sacktor, N. ;
Valcour, V. ;
Wojna, V. E. .
NEUROLOGY, 2007, 69 (18) :1789-1799
[2]   Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy [J].
Bhaskaran, Krishnan ;
Mussini, Cristina ;
Antinori, Andrea ;
Walker, Ann Sarah ;
Dorrucci, Maria ;
Sabin, Caroline ;
Phillips, Andrew ;
Porter, Kholoud .
ANNALS OF NEUROLOGY, 2008, 63 (02) :213-221
[3]   Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy [J].
Canestri, Ana ;
Lescure, Francois-Xavier ;
Jaureguiberry, Stephane ;
Moulignier, Antoine ;
Amiel, Corinne ;
Marcelin, Anne Genevieve ;
Peytavin, Gilles ;
Tubiana, Roland ;
Pialoux, Gilles ;
Katlama, Christine .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (05) :773-778
[4]   Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression [J].
Cysique, Lucette A. ;
Brew, Bruce J. .
JOURNAL OF NEUROVIROLOGY, 2011, 17 (02) :176-183
[5]   Defining and evaluating HIV-Related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers [J].
Gisslen, Magnus ;
Hagberg, Lars ;
Rosengren, Lars ;
Brew, Bruce J. ;
Cinque, Paola ;
Spudich, Serena ;
Price, Richard W. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2007, 2 (01) :112-119
[6]   HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study [J].
Heaton, R. K. ;
Clifford, D. B. ;
Franklin, D. R. ;
Woods, S. P. ;
Ake, C. ;
Vaida, F. ;
Ellis, R. J. ;
Letendre, S. L. ;
Marcotte, T. D. ;
Atkinson, J. H. ;
Rivera-Mindt, M. ;
Vigil, O. R. ;
Taylor, M. J. ;
Collier, A. C. ;
Marra, C. M. ;
Gelman, B. B. ;
McArthur, J. C. ;
Morgello, S. ;
Simpson, D. M. ;
McCutchan, J. A. ;
Abramson, I. ;
Gamst, A. ;
Fennema-Notestine, C. ;
Jernigan, T. L. ;
Wong, J. ;
Grant, I. .
NEUROLOGY, 2010, 75 (23) :2087-2096
[7]   Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study [J].
Lescure, Francois-Xavier ;
Omland, Lars Haukali ;
Engsig, Frederik Neess ;
Roed, Casper ;
Gerstoft, Jan ;
Pialoux, Gilles ;
Kronborg, Gitte ;
Larsen, Carsten Schade ;
Obel, Niels .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) :235-243
[8]   CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment [J].
Mattsson, Niklas ;
Zetterberg, Henrik ;
Hansson, Oskar ;
Andreasen, Niels ;
Parnetti, Lucilla ;
Jonsson, Michael ;
Herukka, Sanna-Kaisa ;
van der Flier, Wiesje M. ;
Blankenstein, Marinus A. ;
Ewers, Michael ;
Rich, Kenneth ;
Kaiser, Elmar ;
Verbeek, Marcel ;
Tsolaki, Magda ;
Mulugeta, Ezra ;
Rosen, Erik ;
Aarsland, Dag ;
Visser, Pieter Jelle ;
Schroeder, Johannes ;
Marcusson, Jan ;
de Leon, Mony ;
Hampel, Harald ;
Scheltens, Philip ;
Pirttilae, Tuula ;
Wallin, Anders ;
Jonhagen, Maria Eriksdotter ;
Minthon, Lennart ;
Winblad, Bengt ;
Blennow, Kaj .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04) :385-393
[9]   The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease [J].
McKhann, Guy M. ;
Knopman, David S. ;
Chertkow, Howard ;
Hyman, Bradley T. ;
Jack, Clifford R., Jr. ;
Kawas, Claudia H. ;
Klunk, William E. ;
Koroshetz, Walter J. ;
Manly, Jennifer J. ;
Mayeux, Richard ;
Mohs, Richard C. ;
Morris, John C. ;
Rossor, Martin N. ;
Scheltens, Philip ;
Carrillo, Maria C. ;
Thies, Bill ;
Weintraub, Sandra ;
Phelps, Creighton H. .
ALZHEIMERS & DEMENTIA, 2011, 7 (03) :263-269
[10]   Changing incidence of central nervous system diseases in the EuroSIDA cohort [J].
Monforte, AD ;
Cinque, P ;
Mocroft, A ;
Goebel, FD ;
Antunes, F ;
Katlama, C ;
Justesen, US ;
Vella, S ;
Kirk, O ;
Lundgren, J .
ANNALS OF NEUROLOGY, 2004, 55 (03) :320-328